Beyond the PSA test: How to better stratify a patient's risk of prostate cancer

JAAPA. 2017 Aug;30(8):51-54. doi: 10.1097/01.JAA.0000521148.78442.d5.

Abstract

The primary method of screening for and detecting prostate cancer is the prostate-specific antigen (PSA) test. Although this test is very prostate-specific, it is not cancer-specific; conditions other than prostate cancer can cause an elevated PSA. Many efforts have been made to discover more specific tests and methods beyond the PSA. This article describes several literature-supported tests and methods to better stratify a man's risk of having prostate cancer.

MeSH terms

  • Antigens, Neoplasm / genetics
  • Early Detection of Cancer / methods*
  • Humans
  • Male
  • Mass Screening / methods*
  • Middle Aged
  • Prostate-Specific Antigen / analysis*
  • Prostate-Specific Antigen / metabolism
  • Prostatic Neoplasms / diagnosis*
  • Prostatic Neoplasms / genetics
  • Risk Assessment / methods
  • Risk Factors

Substances

  • Antigens, Neoplasm
  • prostate cancer antigen 3, human
  • Prostate-Specific Antigen